Nicotine in breast milk disrupts infants' sleep patterns
September 04, 2007
A study from the Monell Chemical Senses Center reports that nicotine in the breast milk of lactating mothers who smoke cigarettes disrupts their infants' sleep patterns.
"Infants spent less time sleeping overall and woke up from naps sooner when their mothers smoked prior to breastfeeding," says lead author Julie A. Mennella, PhD, a psychobiologist at Monell.
The findings, published in the journal Pediatrics, raise new questions regarding whether nicotine exposure through breast milk affects infant development.
While many women quit or cut down on smoking while pregnant, they often relapse following the birth of the baby. Mennella comments, "Because nicotine is not contraindicated during lactation, mothers may believe that smoking while breastfeeding will not harm their child as long as the child is not exposed to passive smoke. However, there has been very little research on either short- or long-term effects of nicotine delivered through breast milk."
Nicotine is a pharmacological stimulant that affects the developing brain and has been shown to cause long-term behavioral and learning deficits.
In the Monell study, researchers measured the feeding behavior and sleep patterns of 15 breastfed infants over a 3-1/2 hour observation period on two separate days. The infants were between two and seven months of age. All mothers were current smokers who abstained from smoking for at least 12 hours before each observation period.
Each mother smoked one to three cigarettes immediately prior to the observation period on one day and refrained from smoking on the other. On both occasions, mothers breastfed their infants on demand over the ensuing 3-1/2 hours. Following each feed, mothers laid infants down on their backs in a crib or on the floor.
An actigraph strapped to the infant's ankle enabled researchers to measure activity and sleep time. Levels of nicotine and cotinine, a major metabolite of nicotine, were measured in breast milk samples provided by the mothers before each feed, allowing researchers to determine the dose of nicotine passed to each infant.
Total sleep time over the 3-1/2 hours declined from an average of 84 minutes when mothers refrained from smoking to 53 minutes on the day they did smoke, a 37% reduction in infant sleep time. This was due to a shortening of the longest sleep bout, or nap, and to reductions in the amount of time spent in both active and quiet sleep.
The level of sleep disruption was directly related to the dose of nicotine infants received from their mothers' milk, consistent with a role for nicotine in causing the sleep disruptions.
Infants consumed the same amount of breast milk on both days, suggesting that they were accepting of tobacco flavor in breast milk. Previous research from Mennella's laboratory has shown that infants demonstrate increased enjoyment of flavors experienced through transmission in breast milk.
Noting that children whose mothers smoke are more likely to smoke as teenagers, Mennella speculates that early experiences with tobacco flavor during breastfeeding may increase its appeal later in life.
She comments that additional studies are needed to examine the long-term developmental effects of nicotine delivered through breast milk.
An earlier study from Mennella's lab demonstrated that breast milk nicotine levels peak 30 - 60 minutes after smoking one or two cigarettes and clear by three hours after the smoking episode. Emphasizing the many benefits of breastfeeding on infant health and development, Mennella notes that lactating mothers who smoke occasionally can time their smoking episodes to minimize nicotine exposure to their child.
The present findings highlight the need for targeted smoking cessation programs that address issues relevant to lactating women. Mennella suggests that concerns about tobacco flavor in their milk and disruptions of their infants' sleep may help motivate breastfeeding mothers to abstain from smoking.
Lauren M. Yourshaw and Lindsay K. Morgan also contributed to the study.
Monell Chemical Senses Center

|
The Nicotine Conspiracy
by Arcturus Publishing
In 2008 Allen Carr's Easyway to Stop Smoking celebrated its 25th anniversary in the knowledge that it has become the global leader in the field of drug-free smoking cessation. There are currently over 100 clinics in 38 countries and a publishing programme with sales of over 13 million books in 50 countries. The organisation continues to grow rapidly and the method is conservatively estimated to have cured more than 10 million smokers worldwide.
Despite the phenomenal success and popularity of the method, Allen Carr's Easyway remains ignored by the Government and unavailable on the NHS which prefers to supply nicotine to addicts at taxpayers' expense via gums, patches etc and so perpetuates the addiction. In fact, the pharmaceutical industry, aided and abetted by the government...
|

|
My Lady Nicotine A Study in Smoke
by J. M. (James Matthew) Barrie (Author)
This book is part of the TREDITION CLASSICS series. The creators of this series are united by passion for literature and driven by the intention of making all public domain books available in printed format again - worldwide. At tredition we believe that a great book never goes out of style. Several mostly non-profit literature projects provide content to tredition. To support their good work, tredition donates a portion of the proceeds from each sold copy. As a reader of a TREDITION CLASSICS book, you support our mission to save many of the amazing works of world literature from oblivion.
|

|
Nicotine Safety and Toxicity
by Neal L. Benowitz (Editor)
Nicotine has been developed as a medication to assist smoking cessation, and is being considered as a possible drug for long-term maintenance of non-smoking. It is also undergoing evaluation as a possible treatment for several medical disorders, including ulcerative colitis, Alzheimer's disease, Parkinson's disease, Tourette's syndrome, attention deficit disorder, spasticity, and sleep apnea. Understanding its safety and toxicity is essential for drug developers, drug regulators, and clinicians making risk/benefit decisions about long-term nicotine therapy. Research on nicotine toxicity is also relevant to ongoing research on tobacco and health aimed at understanding the role of nicotine in contributing to tobacco-induced diseases. This book reviews the current scientific understanding...
|

|
If Only I Could Quit: Recovering From Nicotine Addiction
by Karen Casey (Author)
This complete resource brings together personal stories of recovery, Twelve Step guidance, and 90 daily meditations to help us become nicotine-free. If Only I Could Quit is written by one of Hazelden's most popular meditation authors and a recovering nicotine addict.
|

|
The Addicted Brain: Why We Abuse Drugs, Alcohol, and Nicotine (FT Press Science)
by Michael Kuhar (Author)
Addiction destroys lives. In The Addicted Brain, a leading neuroscientist explains how and why this happens–and presents advances in treatment and prevention. Using breathtaking brain imagery and other research, Michael Kuhar, Ph.D., shows the powerful, long-term brain changes that drugs can cause, revealing why it can be so difficult for addicts to escape their grip. In plain English, Kuhar describes why some people are far more susceptible to addiction than others. He illuminates striking neural similarities between drugs and other pleasures potentially capable of causing abuse or addiction–including alcohol, gambling, sex, caffeine, and even Internet overuse. Finally, he outlines the 12 characteristics most often associated with successful treatment. Authoritative and...
|
|
|
Nicotine Anonymous: the Book
by Nicotine Anonymous (Author)
|

|
"I Don't Smoke!": A Guidebook to Break Your Addiction to Nicotine (Joyous Adventures)
by Joseph Cruse (Author)
Are you addicted to Nicotine? Have you attended a smoking cessation program that gave you a good education on tobacco and focused on the cigarette? It's time to try a very different approach to smoking cessation. 'I Don't Smoke!' is about a proven plan that focuses on you—not the nicotine. It's an approach that looks at quitting as a joyous adventure. After all, you're going to be free of a serious addiction—it's like overthrowing a dictator. If you are one of the 47.7 million adult smokers in the United States, chances are you have wanted to—and have tried to—quit smoking. Eighty percent of adult smokers want to quit completely, according to a survey by Gallup and the National Centers for Disease Control and Prevention. But the nicotine in cigarettes is an addictive drug that...
|

|
Nicotine Kiss (Amos Walker Mystery)
by Loren D. Estleman (Author)
In this first paperback edition of Loren Estleman’s signature PI series, Amos Walker, the quintessential hard-boiled detective, proves that he’s mortal after all. Jeff Starzek, an old friend who smuggles cigarettes for a living, saves Walker’s life, getting him to the hospital after he’s taken a bullet in the leg. A month later, still convalescing, Walker gets a panicked phone call from Starzek’s sister. Jeff is missing. One of the few leads is a Homeland Security agent who’s after Starzek, in connection with a counterfeiting operation that may have terrorist ties.
Though Walker doubts Starzek is a terrorist, he finds treasury paper at a church run by Starzek’s brother. Then Starzek’s brother disappears too. Back to square one, Walker follows his best hunch, driving...
|
|
|
Smoking gun: cigarettes are addictive and deadly. So why are teens still smoking? (Close Up: Nicotine).: An article from: Junior Scholastic
by John DiConsiglio (Author)
This digital document is an article from Junior Scholastic, published by Scholastic, Inc. on October 4, 2002. The length of the article is 1268 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Smoking gun: cigarettes are addictive and deadly. So why are teens still smoking? (Close Up: Nicotine). Author: John DiConsiglio Publication: Junior Scholastic (Magazine/Journal) Date: October 4, 2002 Publisher: Scholastic, Inc. Volume: 105 Issue: 3 Page: iv(2)
Distributed by Thomson...
|
|
|
New drugs emerging for nicotine dependence.(Rx): An article from: Internal Medicine News
by Carl Sherman (Author)
This digital document is an article from Internal Medicine News, published by Thomson Gale on February 1, 2005. The length of the article is 582 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: New drugs emerging for nicotine dependence.(Rx) Author: Carl Sherman Publication: Internal Medicine News (Magazine/Journal) Date: February 1, 2005 Publisher: Thomson Gale Volume: 38 Issue: 3 Page: 52(1)
Distributed by Thomson...
|